Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Narender K. Kalyan"'
Autor:
Farooq Nasar, Ali Javadian, Amara Luckay, John H. Eldridge, Siew Yen Chong, Michael Hendry, Christopher L. Parks, Rashed Abdullah, Timothy J. Zamb, Margaret Lee, Peter B. Little, Susan E. Witko, Narender K. Kalyan, Roger E. Price, Becky Nowak, John W. Coleman, Shakuntala Megati, Stephen A. Udem, J. Erik Johnson, Andrew A. Lackner, Cheryl S. Kotash, Valerie Randolf, David K. Clarke, Michael A. Egan
Publikováno v:
Journal of Virology
In previous work, a prototypic recombinant vesicular stomatitis virus Indiana serotype (rVSIV) vector expressing simian immunodeficiency virus (SIV) gag and human immunodeficiency virus type 1 (HIV-1) env antigens protected nonhuman primates (NHPs) f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69194284e6ca8dbfdef96d406f08705b
Autor:
John H. Eldridge, S. M. Cheng, Michael D. Lubeck, Marjorie Robert-Guroff, S. L. Buge, P. D. Markham, Christopher J. Miller, Stephen A. Udem, S. Alipanah, Narender K. Kalyan, Ersell Richardson
Publikováno v:
Journal of Virology. 71:8531-8541
Six female rhesus macaques were immunized orally and intranasally at 0 weeks and intratracheally at 12 weeks with an adenovirus type 5 host range mutant (Ad5hr)-simian immunodeficiency virus SIVsm env recombinant and at 24 and 36 weeks with native SI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79821c9c219dcd4cf3137b8457236c57
https://doi.org/10.1128/jvi.71.11.8531-8541.1997
https://doi.org/10.1128/jvi.71.11.8531-8541.1997
Autor:
Phillip D. Markham, Pranab K. Chanda, Robert J. Natuk, Maria Myagkikh, Mark R. Wade, Narender K. Kalyan, Alan R. Davis, Susan Zolla-Pazner, Shabnam Alipanah, Shri C.S. Murthy, Larry O. Arthur, Robert C. Gallo, Kathy Steimer, Marjorie Robert-Guroff, Satoshi Mizutani, Marvin S. Reitz, Faruk Sinangil, Stephen M. Nigida, Michael D. Lubeck, Jorg Eichberg, Kristine Aldrich, Paul P. Hung
Publikováno v:
Nature Medicine. 3:651-658
A combination AIDS vaccine approach consisting of priming with adenovirus-HIV-1MN gp160 recombinants followed by boosting with HIV-1SF2 gp120 was evaluated in chimpanzees. Long-lasting protection, requiring only three immunizations, was achieved agai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10775f6b9d04dd0a56fd61322128d0d7
https://doi.org/10.1038/nm0697-651
https://doi.org/10.1038/nm0697-651
Autor:
J. Erik Johnson, Narender K. Kalyan, Annaliesa S. Anderson, Kathrin U. Jansen, Ping Zhao, Nigel P. Minton, Mini Sidhu, Elena Severina, Shakuntala Megati, Phillip Kwok Lee, Susan E. Witko, Irina Yurgelonis, Mike Flint, Anne M. Deatly, Yury V. Matsuka, Cheryl S. Kotash, Robert G. K. Donald
Publikováno v:
Microbiology
The Clostridium difficile toxins A and B are primarily responsible for symptoms of C. difficile associated disease and are prime targets for vaccine development. We describe a plasmid-based system for the production of genetically modified toxins in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5d5284a3a79b27c336cec1a5893d14
https://pubmed.ncbi.nlm.nih.gov/23629868
https://pubmed.ncbi.nlm.nih.gov/23629868
Autor:
Cheryl S. Kotash, Rebecca M. Nowak, Kathrin U. Jansen, Shakuntala Megati, Deanne M. Illenberger, Narender K. Kalyan, Emily Braunstein, Lisa K. McNeil, Maninder K. Sidhu, Irene Yurgelonis, J. Erik Johnson, Jennifer Obregon, Vidia Roopchand, Susan E. Witko
Publikováno v:
Immunology letters. 150(1-2)
Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract illness in infants, the elderly, and other high-risk individuals. Despite years of research in this field, there is no effective licensed vaccine to prevent RSV infe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e77da8a58cd7f5e49c17d3c5a94f74b
https://pubmed.ncbi.nlm.nih.gov/23261719
https://pubmed.ncbi.nlm.nih.gov/23261719
Autor:
Narender K. Kalyan, Emily Braunstein, Zhijian Lu, Jimin Zhang, Maninder K. Sidhu, Richard Zollner, Xiaotian Zhong
Publikováno v:
Development of Vaccines: From Discovery to Clinical Testing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fd148551aa2a3b5c6e1556bda153b9a
https://doi.org/10.1002/9781118023648.ch9
https://doi.org/10.1002/9781118023648.ch9
Autor:
Christopher L. Parks, Susan E. Witko, J. Erik Johnson, R. Michael Hendry, George N. Pavlakis, Stephen A. Udem, Narender K. Kalyan, Barbara K. Felber, Maninder K. Sidhu
Publikováno v:
Journal of virological methods. 164(1-2)
Propagation-defective vesicular stomatitis virus (VSV) vectors that encode a truncated G protein (VSV-Gstem) or lack the G gene entirely (VSV-DeltaG) are attractive vaccine vectors because they are immunogenic, cannot replicate and spread after vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a70ba8cac48f5e1eca0cb28a2aec26
https://pubmed.ncbi.nlm.nih.gov/19941901
https://pubmed.ncbi.nlm.nih.gov/19941901
Autor:
James Wilhelm, Shaw Guang Lee, Narender K. Kalyan, Paul P. Hung, Wah-Tung Hum, Ruth S Rappaport
Publikováno v:
Thrombosis and Haemostasis. 63:464-471
SummaryΔ2−89 t-PA is a deletion mutant lacking the finger (F) and epidermal growth factor (EGF) domains; thus, the fibrin interaction of this molecule must be mediated solely by the kringle region. In the present study, the influence of the oligos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::693ad5abf8dcde544fefd84c82d1ae9f
https://doi.org/10.1055/s-0038-1645067
https://doi.org/10.1055/s-0038-1645067
Autor:
David K. C. Cooper, Diane Pawlyk, Min Guo, Farooq Nasar, Margaret Lee, Jacek Kowalski, David K. Clarke, R. Michael Hendry, Priscilla Calderon, Stephen A. Udem, Susan E. Witko, John H. Eldridge, Joanne DeStefano, Seema S Gangolli, Kevin J. Wright, Narender K. Kalyan, Aaron S. Abramovitz, Donna Tummolo, Robert J. Natuk
Publikováno v:
Journal of Virology
Recombinant vesicular stomatitis virus (rVSV) vectors offer an attractive approach for the induction of robust cellular and humoral immune responses directed against human pathogen target antigens. We evaluated rVSV vectors expressing full-length gly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec431c1140810132b2252863306d582b
https://pubmed.ncbi.nlm.nih.gov/16611905
https://pubmed.ncbi.nlm.nih.gov/16611905
Autor:
Paul P. Hung, Alan R. Davis, Michael R. Pisano, Jorg W. Eichberg, Shaw-Guang Lee, Narender K. Kalyan, Marjorie Robert-Guroff, Wah-Tung Hum, Chu-Lai Hsiao, James M. Wilhelm
Publikováno v:
Vaccine. 12(8)
Haemagglutinin (HA), the major surface glycoprotein of influenza virus, is a potent immunogen against which viral neutralizing antibodies are directed. Studies of the three-dimensional structure of HA have identified major antigenic sites on the mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::320c132266f4d2842d496c880e6d613d
https://pubmed.ncbi.nlm.nih.gov/7522383
https://pubmed.ncbi.nlm.nih.gov/7522383